Gomisong, Arlina T.
HRN: 17-23-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/07/2025
12/13/2025
IV
2.25g
Q6h
CAP MR, Gluteal Ulcer
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes